Speaker Profile
Biography
Dr. Diaz is a physician-scientist at Memorial Sloan Kettering Cancer Center. His teams provided the first definitive evidence for using circulating tumor DNA as cancer biomarker for screening, monitoring, and detection of occult disease; and discovered the therapeutic link between immunotherapy and cancer genetics in patients with mismatch repair deficient tumors. This research led to the historic first pan-tumor FDA approval for any solid tumors with this genetic lesion and the first cancer study that resulted in a 100% complete response rate. He is the recipient of numerous recognitions for his work including the Waun Ki Hong Award for Outstanding Achievement in Cancer Research. He is Editor-in-Chief of Cancer Discovery and is an elected member of the Giants of Cancer Care, the AACR Fellows Academy, the American Society of Clinical Investigation, and the American Academy of Physicians. In 2021, Dr. Diaz was appointed by President Joseph Biden to the National Cancer Advisory Board.
Session Abstract – PMWC 2023 Silicon Valley
Track Chair: Cindy Perettie, Roche
- PMWC 2023 Award Ceremony
- Luis Alberto Diaz Jr., MSK
- Razelle Kurzrock, Medical College of Wisconsin - Non-invasive Liquid Biopsy Techniques (PANEL)
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Apostolia Tsimberidou, MD Anderson
- Mandana Kamgar, MD Medical College of Wisconsin
- Mina Nikanjam, UCSD
- Ash Alizadeh, Stanford University - Liquid Biopsy Challenges and Limitations (PANEL)
Chair: Victor Lin, Mary Bird Perkins
- Luis Alberto Diaz Jr., MSK
- Maximilian Diehn, Stanford
- Dana Dilbeck, Agilent
- Emma Shtivelman, Cancer Commons - Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
Chair: Cindy Perettie, Roche Diagnostics
- Eric Peters, Genenetch
- Andrew Mckenzie, Sarah Cannon
- Yang Pan, Gilead
- Alan Sandler, Mirati Therapeutics - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
Chair: Tom Beer, Exact Sceinces
- Liquid Biopsy for Early Cancer Detection (PANEL)
Chair: Priti Hegde, Foundation Medicine
- Daniel Kim, UCSC
- Mike Nolan, Freenome
- Jeffrey Venstrom, Grail Bio
- Kathryn Phillips, UCSF
- Lon Castle, eviCore healthcare
- Tom Beer, Exact Sciences - Liquid Biopsy for Minimal Residual Disease (PANEL)
Chair: Minetta Liu, Natera
- Peter Bach, Delfi diagnostics
- Laura Vantveer, UCSF
- Susan Bobulsky, Adaptive
- Joshua Cohen, Johns Hopkins
- PMWC Showcase
- Harmeet Dhani, Biological Dynamics
- Varsha Rao, Claret Bio - PMWC NCI Showcase
- Xianghong Jasmine Zhou, EarlyDiagnostics